EPIGRAL.BO
Epigral LimitedExplain this page
Arphra AIPlain-English read on Epigral Limited’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
| In USD | FY 2026 |
|---|---|
| Headline | |
| Market cap | $34.96B |
| Enterprise value | $40.63B |
| Multiples | |
| P / E | — |
| P / B | — |
| EV / EBITDA | — |
| EV / Sales | 1.61 |
| EV / FCF | -622.20 |
| Yields | |
| Earnings yield | +9.49% |
| Free cash flow yield | -0.19% |
| Dividend yield | — |
Profitability
| In USD | FY 2026 |
|---|---|
| Margins | |
| Gross margin | +25.45% |
| Operating margin | +15.78% |
| EBITDA margin | +22.44% |
| EBIT margin | +15.78% |
| Pre-tax margin | +13.48% |
| Net margin | +13.14% |
| Cost structure | |
| Cost of revenue / sales | +74.55% |
| R&D intensity | 0.00% |
| SG&A intensity | +9.67% |
| Effective tax rate | +2.58% |
Returns on capital
| In USD | FY 2026 |
|---|---|
| Returns | |
| Return on equity (ROE) | +14.94% |
| Return on assets (ROA) | +9.47% |
| Return on capital (ROC) | +14.28% |
| Return on invested capital (ROIC) | +11.88% |
| Asset turnover | +72.10% |
| DuPont · ROE decomposition | |
| Net margin | +13.14% |
| Asset turnover (× revenue / assets) | +72.10% |
| Equity multiplier (× assets / equity) | +157.79% |
Activity & efficiency
| In USD | FY 2026 |
|---|---|
| Turnover | |
| Asset turnover | 0.72 |
| Fixed-asset turnover | 0.99 |
| Inventory turnover | 5.40 |
| Receivables turnover | 6.06 |
| Payables turnover | 7.25 |
| Days outstanding | |
| Days sales outstanding (DSO) | 60.21 |
| Days inventory outstanding (DIO) | 67.54 |
| Days payables outstanding (DPO) | 50.31 |
| Cash conversion cycle | 77.44 |
Cash flow quality
| In USD | FY 2026 |
|---|---|
| Operating CF / Net income | 1.17 |
| FCF / Net income | -0.02 |
| FCF margin | -0.26% |
| OCF margin | +15.34% |
| CapEx / Revenue | +15.60% |
| CapEx / D&A | 2.34 |
| Stock-based comp / Revenue | 0.00% |
Per-share & shareholder yield
| In USD | FY 2026 |
|---|---|
| EPS · diluted | 76.95 |
| EPS · basic | 76.95 |
| Book value / share | 514.92 |
| Tangible BV / share | 511.33 |
| Sales / share | 585.80 |
| Operating CF / share | 89.85 |
| Free cash flow / share | -1.51 |
| Dividends / share | 3.50 |
| Payout ratio | +4.54% |
| Retention ratio | +95.46% |
Growth
| In USD | FY 2026 | CAGR |
|---|---|---|
| Top-line | ||
| Revenue · YoY | — | — |
| Gross profit · YoY | — | — |
| Profit | ||
| Operating income · YoY | — | — |
| EBITDA · YoY | — | — |
| Net income · YoY | — | — |
| Operating | ||
| EBIT · YoY | — | — |
| R&D · YoY | — | — |
| Per-share | ||
| EPS · diluted · YoY | — | — |
| EPS · basic · YoY | — | — |
Credit & leverage
| In USD | FY 2026 |
|---|---|
| Leverage | |
| Total debt | $5.72B |
| Net debt | $5.67B |
| Net debt / EBITDA | 1.00 |
| Debt / equity | 0.26 |
| Debt / assets | +16.32% |
| Equity / assets | +63.37% |
| Coverage | |
| EBITDA / interest expense | 7.88 |
| Operating income / interest | 5.54 |
| Interest expense | $719.6M |
| Liquidity | |
| Current ratio | 1.16 |
| Quick ratio | 0.59 |
| Cash ratio | 0.01 |
| Working capital | $1.16B |
| Working capital / revenue | +4.60% |
Historical multiples · μ ± σ bands
3 fiscal-year-end observations from key_metrics. Mean is dashed; light-green band is ±1σ, light-red band ±2σ. The dot marks the most recent value; the cheap / fair / rich verdict uses z-score against the issuer's own history (yields inverted — a high yield is cheap).
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| P / E | — | — | — |
| P / B | — | — | — |
| EV / EBITDA | — | — | — |
| EV / Sales | 1.61x | 3.37x | 3.06x |
| Earnings yield | 9.5% | 4.5% | 4.0% |
| FCF yield | -0.2% | 3.1% | -0.0% |
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Gross margin | — | — | — |
| Operating margin | — | — | — |
| Net margin | — | — | — |
| ROE | 14.9% | 18.8% | 15.6% |
| ROA | 9.5% | 11.3% | 7.0% |
| ROIC | 12.8% | 22.5% | 9.2% |
| Metric | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Debt / equity | — | — | — |
| Net debt / EBITDA | 1.00 | 0.81 | 2.02 |
| Interest coverage | — | — | — |
| Current ratio | 1.16x | 1.57x | 0.64x |
| Quick ratio | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).